Solventum (SOLV) EBITDA Margin (2023 - 2026)
Solventum (SOLV) recorded EBITDA Margin of 14.21% in Q2 2026, down 1.33 percentage points from 15.55% a year earlier but up 3.45 percentage points from the prior quarter.
Powered by 
Analysis
Solventum (SOLV) EBITDA Margin (2023 - 2026) Analysis & Trends
On a TTM basis, Solventum's EBITDA Margin came in at 31.07% as of Jun 30, 2026, up 15.44 percentage points year-over-year; for FY2025, it came in at 32.07%, up 12.80 percentage points from FY2024.
- Annual EBITDA Margin has a three-year change of +4.14 percentage points (FY2022 to FY2025).
- Across earlier years, EBITDA Margin came in at 19.28% in FY2024 (-8.21 pp), 27.49% in FY2023 (-0.45 pp) and 27.93% in FY2022.
- Quarterly EBITDA Margin has ranged from 10.76% in Q1 2026 to 86.40% in Q3 2025 over the past five years.
- On a year-over-year basis, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of +2.69 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 66.81 percentage points in Q3 2025, against a drop of 12.99 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 10.76% (Q1 2026), 12.06% (Q4 2025) and 86.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.62% |
| 10 | Solventum | 14.99 Bn | 11.51 Bn | 1.29 Bn | 14.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.21% |
| Mar 31, 2026 | 10.76% |
| Dec 31, 2025 | 12.06% |
| Sep 30, 2025 | 86.40% |
| Jun 30, 2025 | 15.55% |
| Mar 31, 2025 | 13.57% |
| Dec 31, 2024 | 13.78% |
| Sep 30, 2024 | 19.60% |
| Jun 30, 2024 | 18.12% |
| Mar 31, 2024 | 25.79% |
| Dec 31, 2023 | 26.77% |
| Sep 30, 2023 | 31.24% |
| Jun 30, 2023 | 26.49% |
| Mar 31, 2023 | 25.36% |
API Access
Solventum EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SOLV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SOLV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SOLV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();